In summary, a wealth of animal and human analysis has presented evidence the CCL2-CCR2 axis is vital from the development of cardiovascular disease, as well as the success of pharmacological targeting research in the CCL2-CCR2 axis holds assure for the gradual transition to clinical trials. Even though the CCL2-CCR2 axis-centered https://evansb222nzk5.iyublog.com/profile